Articles

David Tepper’s Appaloosa and Soros Fund Management diverge on Boeing Co., securities filings late Thursday show.

Shares of vaccine makers lost ground Thursday, hit by news that President-elect Donald Trump was naming vaccine skeptic and former presidential hopeful Robert F. Kennedy Jr. as his pick to lead the U.S. Department of Health and Human Services.

Michael Burry, the hedge-fund investor made famous by Michael Lewis’s book “The Big Short,” upped his bets on Chinese stocks during the third quarter — but he’s also making sure to protect his downside.

Gold went from setting records to a tough November losing streak. Here’s what changed.

Federal Reserve Chair Jerome Powell said Thursday that the economy is in a good place, with inflation on a sustainable path back to the central bank’s 2% target, and that he expects inflation to continue to come down on a “sometimes bumpy” path.

Amazon is now offering upfront pricing for virtual care for ailments such as men’s hair loss and ED.

Worries that EV tax credits may go away under the Trump administration hit a fever pitch on Thursday, dragging down the stocks.

The U.S. dollar remains an unabashed beneficiary of Donald Trump’s presidential election win — and it’s relentless rise is causing significant pain for some emerging-market assets and commodities.

Take steps now to avoid a financial mess later.

Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease drug that the company developed with Japanese partner Eisai — reversing an earlier decision not to approve the drug.

Cryptocurrencies are making their way through the plumbing of the financial market — and one of the most interesting ways they’re doing this is by reaching into the U.S. government-debt market.

The chances are “‘pretty high” that income-tax rates will stay where they are after 2025, one expert said.